Final-Program-ATS-2023-AP.vp

30

SATURDAY • MAY 20

1:35 Questions and Answers for Talks 7 and 8 M.E. Rebuli, PhD, Chapel Hill, NC A.P. Tackett, PhD, Columbus, OH 1:45 Break 1:55 E-Cig/Tobacco Cessation Approaches: Inpatient Consult Service H. Kathuria, MD, ATSF, Boston, MA 2:25 E-Cig/Tobacco Cessation Approaches: Adult Outpatient Clinic T. Fisher, DNP, APN, Philadelphia, PA 2:55 E-Cig/Tobacco Cessation Approaches: Pediatric Outpatient Clinic A.M.H. Casey, MD, Boston, MA 3:25 Treatment Approaches Panel DELECNAC DELECNAC

• improve the quality of care provided to those with nicotine dependence by understanding how to develop inpatient and outpatient treatment services The primary goal of this session is to provide learners with up to date, evidence-based knowledge and skills in the assessment and treatment of nicotine dependence. The course will provide timely information about tobacco products, associated risks, and how this knowledge informs the approach to tobacco cessation. The treatment approach will be individualized and evidence-based, and will span all age groups (adolescent to adult) and practice settings (inpatient and outpatient). Timely updates about regulation/policy, cannabinoid use in e-cigarettes, and EVALI will be shared. Course faculty include multidisciplinary clinical, research, and advocacy experts. Participants will attend breakout sessions to refine new skills. Chairing: S.C. Sadreameli, MD, MHS, Baltimore, MD S.C. Sadreameli, MD, MHS, Baltimore, MD 8:05 Product Overview: From Cigarettes to ENDS and More S.C. Sadreameli, MD, MHS, Baltimore, MD 8:30 Tobacco Policy and Regulation Updates G. Ewart, MHS, Washington, DC 8:55 Questions and Answers for Talks 1 and 2 S.C. Sadreameli, MD, MHS, Baltimore, MD G. Ewart, MHS, Washington, DC 9:05 How Do We Take an Effective History? S.D. Krefft, MD, MPH, Aurora, CO 9:30 Motivational Interviewing as an Approach to Cessation M. Eakin, PhD, Baltimore, MD 9:55 Questions and Answers for Talks 3 and 4 S.D. Krefft, MD, MPH, Aurora, CO M. Eakin, PhD, Baltimore, MD 10:05 Break 10:15 Treatment of Adult Nicotine Dependence A.E. Lang, PharmD, Fort Eustis, VA 10:40 Treating Tobacco Dependence in the Pediatric Clinic H.J. Farber, MD, MSPH, ATSF, Houston, TX 11:05 Questions and Answers for Talks 5 and 6 A.E. Lang, PharmD, Fort Eustis, VA H.J. Farber, MD, MSPH, ATSF, Houston, TX 11:15 Lunch 11:45 Breakout Session 12:45 EVALI: Diagnosis, Treatment, Prevention M.E. Rebuli, PhD, Chapel Hill, NC 1:10 E-Cigarettes and Cannabinoids A.P. Tackett, PhD, Columbus, OH DELECNAC DELECNAC DELECNAC DELECNAC A.E. Lang, PharmD, Fort Eustis, VA M.E. Rebuli, PhD, Chapel Hill, NC 8:00 Opening Remarks

H. Kathuria, MD, ATSF, Boston, MA T. Fisher, DNP, APN, Philadelphia, PA A.M.H. Casey, MD, Boston, MA 3:55 Concluding Remarks and Dismissal A.E. Lang, PharmD, Fort Eustis, VA

BASIC • TRANSLATIONAL POSTGRADUATE COURSE CME Credits Available: 6

PG11 A HANDS-ON INTRODUCTION TO STUDYING THE LUNG MICROBIOME R Pre-registration and additional fees required. Attendance is limited. Member: $440 In-Training Member: $255 LMIC Member: $310 LMIC In-Training Member: $180 Non-Member: $540 In-Training Non-Member: $380 R Registrants must bring a laptop to the course to view the course material. Assemblies on Pulmonary Infections and Tuberculosis; Allergy, Immunology and Inflammation 8:00 AM - 4:00 PM Marriott Marquis Washington Liberty Ballroom, Salon L (Level M4) Target Audience Research scientists interested in designing, performing, and understanding the analysis of lung and airway microbiome samples using sequencing-based techniques. Objectives At the conclusion of this session, the participant will be able to: • apply research design and analytical approaches needed to conduct culture-independent assessment of microbiome communities in respiratory specimens • integrate microbiome sequencing results with current culture-based models of respiratory infection and re-evaluate disease paradigms

ATS 2023 • Washington, DC